Abstract: Provided is an antibody that exhibits pH dependence and specifically binds to a sulfated glycosaminoglycan (sGAG). An antibody specifically binding to a sulfated glycosaminoglycan that is at least one selected from the group consisting of the following (1) to (3): (1) an antibody that contains a heavy chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 1, CDR2 comprising an amino acid sequence represented by SEQ ID NO: 2 and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 3, and a light chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 4, CDR2 comprising an amino acid sequence represented by LGS and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 6; (2) an antibody that contains a heavy chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 7, CDR2 comprising an amino acid sequence represented by SEQ ID NO: 8 and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 9, and a light chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 10, CDR2 comprising an amino acid sequence represented by AAS and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 12; and (3) an antibody that contains a heavy chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 13, CDR2 comprising an amino acid sequence represented by SEQ ID NO: 14 and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 15, and a light chain having CDR1 comprising an amino acid sequence represented by SEQ ID NO: 16, CDR2 comprising an amino acid sequence represented by WAS and CDR3 comprising an amino acid sequence represented by SEQ ID NO: 18.
| # | Name | Date |
|---|---|---|
| 1 | 202417078684-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [16-10-2024(online)].pdf | 2024-10-16 |
| 2 | 202417078684-STATEMENT OF UNDERTAKING (FORM 3) [16-10-2024(online)].pdf | 2024-10-16 |
| 5 | 202417078684-Sequence Listing in PDF [16-10-2024(online)].pdf | 2024-10-16 |
| 6 | 202417078684-REQUEST FOR EXAMINATION (FORM-18) [16-10-2024(online)].pdf | 2024-10-16 |
| 7 | 202417078684-PROOF OF RIGHT [16-10-2024(online)].pdf | 2024-10-16 |
| 8 | 202417078684-PRIORITY DOCUMENTS [16-10-2024(online)].pdf | 2024-10-16 |
| 9 | 202417078684-POWER OF AUTHORITY [16-10-2024(online)].pdf | 2024-10-16 |
| 10 | 202417078684-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [16-10-2024(online)].pdf | 2024-10-16 |
| 11 | 202417078684-FORM 18 [16-10-2024(online)].pdf | 2024-10-16 |
| 12 | 202417078684-FORM 1 [16-10-2024(online)].pdf | 2024-10-16 |
| 13 | 202417078684-DRAWINGS [16-10-2024(online)].pdf | 2024-10-16 |
| 14 | 202417078684-DECLARATION OF INVENTORSHIP (FORM 5) [16-10-2024(online)].pdf | 2024-10-16 |
| 15 | 202417078684-COMPLETE SPECIFICATION [16-10-2024(online)].pdf | 2024-10-16 |
| 16 | 202417078684-Others-251124.pdf | 2024-11-28 |
| 17 | 202417078684-Others-251124-1.pdf | 2024-11-28 |
| 18 | 202417078684-GPA-251124.pdf | 2024-11-28 |
| 19 | 202417078684-Correspondence-251124.pdf | 2024-11-28 |
| 20 | 202417078684-FORM 3 [08-04-2025(online)].pdf | 2025-04-08 |